yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37699156-10628D72-1B05-45D5-929A-3E2FC4E910FF
Q37699156-10628D72-1B05-45D5-929A-3E2FC4E910FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37699156-10628D72-1B05-45D5-929A-3E2FC4E910FF
Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.
P2860
Q37699156-10628D72-1B05-45D5-929A-3E2FC4E910FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37699156-10628D72-1B05-45D5-929A-3E2FC4E910FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c9486cc86e23316a03a18de775883adc8cdcd305
P2860
Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group